Oregon § 459A.260 State preemption of local laws

Oregon Statutes

§ 459A.260 — State preemption of local laws

Oregon § 459A.260

Vol.13

Title 36AHousing; Lottery and Games; Environment

Ch. 459AReuse and Recycling

This text of Oregon § 459A.260 (State preemption of local laws) is published on Counsel Stack Legal Research, covering Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Or. Rev. Stat. § 459A.260 (2026).

Text

Except as expressly authorized by state law, ORS 459A.200 to 459A.266 supersede and preempt any ordinance or other regulation enacted before, on or after September 29, 2019, by the governing body of a city, county or other political subdivision of this state that establishes or requires a program for the collection, by or on behalf of covered manufacturers, of:

(1)Biologics;

(2)Covered drugs;

(3)Drugs for which a covered manufacturer administers a drug take-back program as part of a risk evaluation and mitigation strategy under the oversight of the federal Food and Drug Administration;

(4)Drugs that are used for animal medicines, including but not limited to parasiticide drugs for animals;

(5)Drugs administered in a clinical setting; or

(6)Dialysis concentrates and solutions used for

Free access — add to your briefcase to read the full text and ask questions with AI

Except as expressly authorized by state law, ORS 459A.200 to 459A.266 supersede and preempt any ordinance or other regulation enacted before, on or after September 29, 2019, by the governing body of a city, county or other political subdivision of this state that establishes or requires a program for the collection, by or on behalf of covered manufacturers, of:
(1) Biologics;
(2) Covered drugs;
(3) Drugs for which a covered manufacturer administers a drug take-back program as part of a risk evaluation and mitigation strategy under the oversight of the federal Food and Drug Administration;
(4) Drugs that are used for animal medicines, including but not limited to parasiticide drugs for animals;
(5) Drugs administered in a clinical setting; or
(6) Dialysis concentrates and solutions used for kidney dialysis in a patient’s home.